Day: February 14, 2022

Consolidates Legal & Regulatory Functions and Group Risk Management ResponsibilitiesNasdaq Announces Updates to Market Technology Leadership Nasdaq, Inc. announced the retirement of Lars Ottersgård, Executive Vice President for Market Technology, after 16 years providing leadership to the organization. As a result, the company is appointing two senior leaders – Jamie King and Roland Chai – to drive forward its Anti-Financial Crime and Market Infrastructure Technology businesses, respectively.NEW YORK, Feb. 14, 2022 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ), today announced the retirement of Lars Ottersgård, Executive Vice President for Market Technology, after 16 years providing leadership to the organization. Ottersgård will transition into an advisory role on April 30, 2022, until his formal retirement on August...

Revenue increased 57.1% quarter-over-quarter to $6.99 million Company expects to continue strong revenue growth in FY 2022 LOS ANGELES, Feb. 14, 2022 (GLOBE NEWSWIRE) — — via NewMediaWire – Troika Media Group, Inc. (Nasdaq: TRKA) (“Troika” or “Company”), a brand consultancy and marketing innovations company that provides integrated branding and marketing solutions for global brands, today announced financial results for its second quarter of fiscal year 2022 ended December 31, 2021. Second Quarter and Year-to-Date Financial and Operational HighlightsRevenue increased 57.1% to $6.99 million in Q2 2022, compared to the prior year quarter Adjusted EBITDA was $(1.95) million in Q2 2022, compared $0.8 million to the prior year quarter Revenue increased 78.76% to $15.34 million for the first six months...

VANCOUVER, British Columbia, Feb. 14, 2022 (GLOBE NEWSWIRE) — XR Immersive Tech Inc. (“Immersive Tech”, or the “Company”) (CSE:VRAR) (FSE:79W) (OTCQB: FNTTF) is pleased to announce that its recent acquisition Synthesis VR Inc. on January 6, 2022, (“Synthesis VR”) has launched full support for all Android standalone/mobile head-mount display (“HMD”) VR headsets and XR devices including a first to market digital rights management (“DRM”) solution for its network of over 300 global VR arcade operators and beyond. This allows operators to expand their facilities and take advantage of the latest standalone HMDs and allows content creators to distribute their content to a much wider customer base. This paves the way for operators to be able to launch next generation stand alone hardware systems based on mobile processors. Synthesis VR...

Hässleholm, Sweden, February 14th, 2022 Eolus Vind AB:s Year-end report for 2021 will be announced on Friday February 18th, 2022, at 8.30 AM CET. At 10.00 AM CET the same day an audiocast and teleconference in English will be held and the report will be presented by CEO Per Witalisson and CFO Catharina Persson. In connection with the presentation, it is possible to ask questions through the teleconference or in written form through the audiocast. If you wish to participate in the teleconference, click the link for details:  https://financialhearings.com/event/44081 The presentation can also be followed live at:https://tv.streamfabriken.com/eolus-q4-2021/register For further information contact: Per Witalisson, CEO, +46 70-265 16 15Johan Hammarqvist, Head of Communications, +46 720 50 59 11 About Eolus:Eolus Vind AB is one of the leading...

SUNNYVALE, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP™ Cell Therapy Heart Failure Trial (ClinicalTrials.gov Identifier: NCT02438306), just one week after receiving Breakthrough Device Designation from the FDA. The DSMB based its review on all available data for the 108 patients enrolled with an additional six crossover patient procedures in the trial to date. The DSMB performed a risk-benefit assessment, indicated no significant safety concerns, and recommended that the study continue as designed.   “It is promising that the most...

ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST) (“Post”), a consumer packaged goods holding company, today announced it has set a record date of February 25, 2022 (the “Record Date”) for the anticipated spin-off of 80.1% of its interest in BellRing Brands (“BellRing”) to Post shareholders. Subject to the satisfaction of certain customary conditions, Post is expected to distribute approximately 78 million shares of common stock of BellRing Distribution, LLC (which will convert into a Delaware corporation prior to the distribution and be renamed BellRing Brands, Inc.) (“New BellRing”) on a pro rata basis to Post shareholders on the distribution date for the spin-off. Based on the number of Post common shares outstanding as of January 31, 2022, Post shareholders would receive 1.261585 shares of New BellRing...

Calibration study results now available in draft paper on medRxiv, a preprint platform for health sciences, as “DNA Aptamer Gold Nanoparticle Colorimetric Diagnostic Test Kit of Saliva Samples for SARS-CoV-2 Virus Linked to Mobile Phone Application” AptameX is the world’s first scale application of DNA aptamers in a commercial diagnostics setting, and holds advantages in performance, cost, and quality of production over other rapid tests Second-generation test kits are currently being sent for preproduction evaluation Evaluating clinical investigation site in Australia for final CE Mark requirementZURICH, Switzerland, Feb. 14, 2022 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) is pleased to announce the availability of its calibration...

The proposed partnership will encompass three potential strategic pillars across supply of API, commercialization of prescription products, and co-development of pharmaceutical drug candidates.Avicanna X Tetra Bio-Pharma Avicanna X Tetra Bio-PharmaTORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based, cannabinoid-based products, is pleased to announce that it has executed a non-binding term sheet with Tetra Bio-Pharma (“Tetra”) to assess entering into a strategic partnership comprising of three strategic pillars, including:The registration and commercialization of Tetra’s various prescription products...

PBI-0451 administered twice-daily as a stand-alone agent achieves and maintains PK exposures anticipated to provide potent antiviral activity against SARS-CoV-2 PBI-0451 has been generally well-tolerated and has shown good oral bioavailability Company to host conference call and webcast Tuesday, February 15, 2022 at 3:00 p.m. PT / 6:00 p.m. ET CARLSBAD, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential novel direct-acting, oral antiviral drug candidate for the treatment and prevention of SARS-CoV-2 infections and associated diseases (i.e., COVID-19), announced that interim clinical data from its ongoing PBI-0451 Phase 1 trial in healthy adult volunteers has been made available to registered conference attendees at the...

Tel Aviv, Israel, Feb. 14, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that ParaZero Ltd. (“ParaZero“), a privately held company engaged in drone technology with an innovative patented safety system for drones, of which Medigus has a 40% ownership stake, confirmed that a drone carrying its ParaZero SafeAirTM system was granted the first authorization for commercial drone deliveries from The Brazilian National Civil Aviation Agency (ANAC). ANAC authorized the manufacturer, Speedbird Aero, to carry out commercial drone deliveries in Brazil. Over the past two years, ParaZero has worked closely with Speedbird Aero to equip the Speedbird Aero DLV-1 NEO drone model...